Staff View for: Dietary supplements containing ephedra :

 Staff view

You must be logged in to Tag Records

Dietary supplements containing ephedra : health risks and FDA's oversight : statement of Marcia Crosse, Acting Director, Health Care--Public Health and Science Issues, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

United States General Accounting Office.

Book Cover
Main Author: Crosse, Marcia.
Published: Washington, D.C. : U.S. General Accounting Office, [2003]
Series: Testimony ; GAO-03-1042 T.
Topics: Ephedra - United States. | Dietary supplements - Government policy - United States. | Consumer protection - United States. | United States. Food and Drug Administration - Evaluation.
Regions: United States.
Tags: Add


Spaces will separate tags.
Use quotes for multi-word tags.

000 02780cam a2200529Ia 4500
001 1503567
005 20170801193920.0
006 m o d f
007 cr an|||||||||
008 031031s2003 dcu ob f000 0 eng d
035 |a(OCoLC)ocm53325746
035 |a(EIUdb)591596
037 |bGAO (202)512-6000 (voice); (202)512-6061 (Fax); (202)512-2537 (TDD)|fpaper copy
040 |aGPO|beng|cGPO|dOCLCQ|dSYB|dOCLCQ|dOCLCF|dOCLCQ|dOCLCO|dOCL|dOCLCQ|dVGM|dEIUdb
043 |an-us---
049 |aIADA
050 4|aRS75|b.C76 2003
074 |a0546-D-01 (online)
086 0 |aGA 1.5/2:GAO-03-1042 T
100 1 |aCrosse, Marcia.
245 10|aDietary supplements containing ephedra :|bhealth risks and FDA's oversight : statement of Marcia Crosse, Acting Director, Health Care--Public Health and Science Issues, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /|cUnited States General Accounting Office.
260 |aWashington, D.C. :|bU.S. General Accounting Office,|c[2003]
300 |a1 online resource.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
490 1 |aTestimony ;|vGAO-03-1042 T
500 |aTitle from title screen (viewed Oct. 31, 2003).
500 |a"For release ... July 23, 2003."
500 |aPaper version available from: General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
504 |aIncludes bibliographical references.
538 |aSystem requirements: Adobe Acrobat Reader.
538 |aMode of access: Internet from the GAO web site. Address as of 10/31/03: http://www.gao.gov/new.items/d031042t.pdf; current access is available via PURL.
610 10|aUnited States.|bFood and Drug Administration|xEvaluation.
610 17|aUnited States.|bFood and Drug Administration.|2fast|0(OCoLC)fst00549734
650 0|aEphedra|zUnited States.
650 0|aDietary supplements|xGovernment policy|zUnited States.
650 0|aConsumer protection|zUnited States.
650 7|aEvaluation.|2fast|0(OCoLC)fst00916975
650 7|aConsumer protection.|2fast|0(OCoLC)fst00876358
650 7|aDietary supplements|xGovernment policy.|2fast|0(OCoLC)fst00893337
650 7|aEphedra.|2fast|0(OCoLC)fst00913667
651 7|aUnited States.|2fast|0(OCoLC)fst01204155
710 1 |aUnited States.|bGeneral Accounting Office.
776 1 |aCrosse, Marcia.|tDietary supplements containing ephedra : health risks and FDA's oversights : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives|h17 p.|w(OCoLC)53101888
830 0|aTestimony ;|vGAO-03-1042 T.
994 |a92|bIAD

Staff View for: Dietary supplements containing ephedra :